Audit & feedback with educational outreach and facilitation for Traumatic Injury

Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
Screening 3 weeks
Treatment Varies
Follow Up18-month interval (6 to 24 months) after implementation
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will study how to reduce unnecessary tests & procedures in injury admissions, leading to improved healthcare efficiency, cost savings & reduced adverse events.

Eligible Conditions
  • Traumatic Injury


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18-month interval (6 to 24 months) after implementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-month interval (6 to 24 months) after implementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Low-value initial diagnostic imaging
Secondary outcome measures
Low-value specialist consultation
Pre-transfer imaging
Repeat post-transfer imaging
Other outcome measures
Hospital stay
Incremental Cost-Effectiveness Ratios
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Simple audit & feedbackExperimental Treatment1 Intervention
The control arm will receive the quality improvement intervention currently in place in the Québec Trauma Care Continuum (i.e. simple A&F report presenting their performance compared to peers on quality indicators measuring adherence to high-value care and risk-adjusted outcomes) with the addition of quality indicators on low-value care (already planned by provincial authorities for the 2023 evaluation cycle). Simple A&F was chosen for the control because it is standard practice in Québec and in most integrated trauma systems and the effectiveness of A&F for de-implementation has been documented.
Group II: Audit & feedback with educational outreach and facilitationExperimental Treatment1 Intervention
The intervention includes: 1) refinement with end users, 2) an A&F report sent to local governing authorities presenting for each practice: performance compared to peers (simple A&F), a summary message indicating if action is required and a list of potential actions, 3) educational materials (a clinical vignette; consequences of the practice; links to practice guidelines, clinical decision rules and shared decision-making tools; a case review tool), 4) virtual educational meetings with the local trauma Medical Director, trauma program manager and data analyst, and 5) two virtual facilitation visits 2 and 4 months after the transmission of the report to support committees in preparing their action plan.

Find a site

Who is running the clinical trial?

Institut national de la pertinence des actes médicauxUNKNOWN
Audit & Feedback MetalabUNKNOWN
Health Standards OrganisationUNKNOWN

Media Library

Audit & feedback with educational outreach and facilitation Clinical Trial Eligibility Overview. Trial Name: NCT05744154 — N/A
Traumatic Injury Research Study Groups: Audit & feedback with educational outreach and facilitation, Simple audit & feedback
Traumatic Injury Clinical Trial 2023: Audit & feedback with educational outreach and facilitation Highlights & Side Effects. Trial Name: NCT05744154 — N/A
Audit & feedback with educational outreach and facilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05744154 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study actively seeking participants?

" evidence indicates that this trial, which was first published on June 1st 2023 and last updated February 15th 2023, is no longer recruiting participants. Despite this unfortunate reality, there are presently 750 other clinical trials actively seeking patients to take part in the study."

Answered by AI
~19 spots leftby Sep 2025